Press Releases
Cyxone files regulatory submission to start clinical phase 2b study with Rabeximod
23 Jun, 2022 12:23 CESTTara Heitner steps down as CEO of Cyxone
20 Jun, 2022 16:25 CESTRegulatoryMARFirst Berlin Equity Research publishes independent analysis of Cyxone
17 May, 2022 15:36 CESTBulletin from the annual general meeting in Cyxone AB on 16 May 2022
16 May, 2022 11:00 CESTRegulatoryAdjusted proposal regarding election and remuneration of board members prior to the Annual General Meeting of Cyxone AB
12 May, 2022 16:55 CESTRegulatory